Spots Global Cancer Trial Database for A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.
Official Title: A Phase 2 Study Of The Efficacy And Safety Of SU011248 In Patients With Metastatic Breast Cancer
Study ID: NCT00078000
Conditions
Interventions
Study Description
Brief Summary: Assessment of safety and efficacy of SU11248 in patients with metastatic breast cancer who have failed selected other therapies.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Pfizer Investigational Site, Greenbrae, California, United States
Pfizer Investigational Site, Los Angeles, California, United States
Pfizer Investigational Site, San Francisco, California, United States
Pfizer Investigational Site, Aurora, Colorado, United States
Pfizer Investigational Site, Chicago, Illinois, United States
Pfizer Investigational Site, Indianapolis, Indiana, United States
Pfizer Investigational Site, Baltimore, Maryland, United States
Pfizer Investigational Site, Boston, Massachusetts, United States
Pfizer Investigational Site, Boston, Massachusetts, United States
Pfizer Investigational Site, Boston, Massachusetts, United States
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
